help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Hooff, M. H. A.
Right arrow Articles by Schoemaker, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Hooff, M. H. A.
Right arrow Articles by Schoemaker, J.
The Journal of Clinical Endocrinology & Metabolism Vol. 85, No. 4 1394-1400
Copyright © 2000 by The Endocrine Society


Original Studies

Insulin, Androgen, and Gonadotropin Concentrations, Body Mass Index, and Waist to Hip Ratio in the First Years after Menarche in Girls with Regular Menstrual Cycles, Irregular Menstrual Cycles, or Oligomenorrhea1

M. H. A. van Hooff, F. J. Voorhorst, M. B. H. Kaptein, R. A. Hirasing, C. Koppenaal and J. Schoemaker

Research Institute for Endocrinology, Reproduction and Metabolism, Division of Reproductive Endocrinology and Fertility (M.H.A.v.H., M.B.H.K., J.S.) and Department of Epidemiology and Medical Statistics (F.J.V.), Vrije Universiteit Medical Center, 1081 HV Amsterdam; Netherlands Organization for Applied Scientific Research (TNO), Prevention and Health, Child Health Division (R.A.H.), 2301 CE Leiden; and Department of Youth Health Care of the Public Health Care Service Amstelland-de Meerlanden (C.K.), 1185 JC Amstelveen, The Netherlands

Address correspondence and requests for reprints to: M. H. A. van Hooff, Vrije Universiteit Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.


    Abstract
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Discussion
 References
 
Data on changes in hormone concentrations during the first years after menarche are scarce. We studied the relation between gynecological age (age minus age at menarche), hormone concentrations, and body measurements from the 1st to the 6th yr after menarche in 229 observations of girls with regular menstrual cycles, 157 observations of girls with irregular menstrual cycles, and 104 observations of girls with oligomenorrhea.

Body Mass Index, waist circumference, hip circumference, LH, androstenedione, testosterone, and dehydro-epiandrosterone sulphate increased significantly (linear regression, P < 0.05) by gynecological age in all menstrual cycle pattern groups. For PRL and estradiol a significant increase with gynecological age was only documented in the regular menstrual cycle group and for waist to hip ratio only in the irregular menstrual cycle group. No significant correlation could be documented between gynecological age and overnight fasting insulin concentrations or glucose to insulin ratio.

We found no significant correlation between insulin concentrations or glucose to insulin ratio and androgen concentrations. Significant positive correlations were found between LH and androgens.

LH and androgen levels increase during the first years after menarche, and reference values should be adjusted for gynecological age. In these years, no significant correlation between hyperinsulinemia and hyperandrogenemia could be documented.


    Introduction
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Discussion
 References
 
THE INCREASE IN gonadotropins, androgens, oestrogen, and insulin concentrations from prepuberty until menarche is well documented (1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13). Few data are available on changes in concentrations of gonadotropins, androgens, or estrogens during the first years after menarche (8, 9, 10, 14, 15), and no data are available on the relation between gynecological age and insulin concentrations. As gonadotropin and androgen levels differ in girls with regular and irregular menstrual cycles (14, 15, 16), attention should be given to the menstrual cycle pattern in the study of these hormones. To further explore this issue, we studied the relation between gynecological age and gonadotropin, PRL, androgen, and insulin levels in the years after menarche in population-based cohorts of girls with regular menstrual cycles, irregular menstrual cycles, and oligomenorrhea participating in the POMP study (The Puberty Onset Menstrual Cycle Abnormalities: A Prospective Study) (17, 18). In addition, simultaneous changes in body mass index (BMI), waist and hip circumference, and waist to hip ratio (WH ratio) were studied.

Puberty is a state of relative insulin insensitivity and compensating hyperinsulinemia (11, 12, 13, 19, 20, 21). To examine whether the physiological, relative hyperinsulinemia during this period of life goes together with hyperandrogenism or other sequelae as seen in adult patients with the polycystic ovary syndrome (PCOS) (22, 23, 24, 25), we studied the correlation between insulin concentrations and glucose to insulin ratio (GI ratio), on one hand, and body measurements, gonadotropins, and androgens, on the other hand.


    Material and Methods
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Discussion
 References
 
Study population

The methodology of the POMP study has been described in detail elsewhere (17, 18). In summary, the POMP study can be divided into three major phases. In the first phase, 2248 white, ninth grade schoolgirls filled out a questionnaire and were interviewed on their menstrual cycle pattern. The definitions of the menstrual cycle patterns were: 1) regular menstrual cycles: an average length of the cycle between 22 and 41 days, either none or a single cycle with a length less than 22 or more than 41 days during the past year; 2) irregular menstrual cycles: an average length of the cycle between 22 and 41 days, two or more cycles with a length less than 22 or more than 41 days during the past year; 3) oligomenorrhea: an average length of the cycle between 42 and 180 days; 4) secondary amenorrhea: the absence of menstruation for 180 days or more; and 5) polymenorrhea: an average length of the cycle of 21 days or less.

All girls with oligomenorrhea, secondary amenorrhea, or polymenorrhea and a sample of the girls with irregular menstrual cycles were invited for a physical examination and vena puncture. For every girl with oligomenorrhea or secondary amenorrhea who agreed to vena puncture, two girls with regular menstrual cycles were enrolled in the control group. The girls who gave blood were representative samples of the menstrual cycle groups from which they were a member (18).

The adolescents who were interviewed in the first phase of the study were asked approval to have a follow-up questionnaire mailed to them after 18 months. In the second and third phases of the POMP study, adolescents with regular menstrual cycles who participated in vena puncture in the first phase, and all girls with oligomenorrhea, secondary amenorrhea, polymenorrhea, and irregular menstrual cycles, and those who had not yet, or less than 6 months earlier, experienced menarche at the time of the first questionnaire received a second and third questionnaire after 18 and 36 months, respectively. The responders were categorized according to menstrual cycle pattern and were invited for venapuncture.

Three hundred thirty-nine girls gave 490 blood samples. Forty-nine girls gave three blood samples, 98 girls gave two samples, and 147 girls gave one sample. Table 1Go shows the number of adolescents who gave blood in the different phases of the study categorized by menstrual cycle pattern. For the statistical analysis, girls with normogonadotropic secondary amenorrhea were recorded as oligomenorrhea (26). Polymenorrhea was rare, prevalence 0.8% (17). This subgroup was too small for statistical analysis.


View this table:
[in this window]
[in a new window]
 
Table 1. Number of participants with venapuncture in the first, second, and third phases of the POMP study by menstrual cycle pattern

 
The study was approved by the Committee on Ethics of Research involving Human Subjects of the Vrije Universiteit Medical Center in Amsterdam. All girls gave informed consent. The majority of the participants were under age. They were informed that they needed approval of their parents to participate in the study. Parents consented by telephone or were present when the blood was taken. On the basis of the idea that adolescents gradually mature between ages of 14 and 18 yr, this policy was developed in collaboration with our institutional review board.

Methods

Physical examination.Weight was measured to the nearest 0.5 kg using a mobile spring scale (Seca, Hamburg, Germany), and height was measured to the nearest 0.5 cm using a mobile measuring rod (Microtoise; Stanley mabo, Poissy, France). Waist circumference was measured to the nearest 0.5 cm with a plastic tape at the smallest frontal waist diameter, usually at the level of the umbilicus. Hip circumference was measured at the broadest part of the lower body, usually at the level of the trochanters (27). Body hair grading was assessed according to the Ferriman and Gallwey (F&G) score (28). Abnormal body hair was defined as a F&G score of 1 or more, and hirsutism as a F&G score of 8 or more.

Blood sampling and hormone measurements.In the first phase of the study, blood was taken at school between 1200 and 1700 h. In the second and third phases of the study, blood was taken after an overnight fast between 0800 and 1000 h at school or at home. In girls with regular or irregular menstrual cycles the blood was taken between the 1st and 10th day of the menstrual cycle. To exclude the influence of a midcycle LH peak, blood from these girls should, in retrospect, have been taken at least 18 days before the next menstruation. In oligomenorrheic girls the blood sample should have been taken at least 2 weeks after the 1st day of a period and at least 3 weeks before the next period. This procedure excludes the possible influence of periovulatory hormonal changes and postovulatory progesterone production on the LH and androgen concentrations, which extends itself into the follicular phase of the next menstrual cycle (29, 30, 31, 32, 33, 34). In secondary amenorrhea, blood samples were taken at random.

All hormones were determined by commercially available kits. LH and FSH were determined by immunofluorometric assays (Amerlite; Amersham Pharmacia Biotech UK, Amersham, UK). PRL concentrations were measured by an immunoradiometric assay (Medgenix Diagnostics, Fleurus Belgium); estradiol (E2) concentrations were measured by a RIA (Estradiol-2; Sorin Biomedica, Saluggia, Italy); androstenedione ({Delta}A) and dehydroepiandrosterone-sulphate (DHEAS) concentrations were measured by a RIA; and testosterone (T) was measured by a double antibody RIA (Coat a Count; DPC, Los Angeles, CA). Insulin concentrations were measured by RIA (Insik-5; Sorin Biomedica). Glucose was measured by automatic hexokinase method.

Androgens and E2 are expressed in standard international units. The conversion factor to metric units is described by the following equations: for {Delta}A µg/L * 3.49 = nmol/L; for T ng/mL * 3.47 = nmol/L; for DHEAS ng/ml * 0.00271 = µmol/L; and E2 pg/ml * 3.67 = pmol/L.

LH, FSH, {Delta}A, T, and DHEAS were measured in all samples. E2 and PRL concentrations were measured in the first sample of girls with regular and irregular menstrual cycles and in all samples of girls with oligo- or amenorrhea. Insulin and glucose concentrations were only measured in samples taken after an overnight fast in the second and third phases of the study.

Statistics.The data were analyzed with BMDP statistical software package (BMDP statistical software, Cork, Ireland). Means ± SEM are presented. Although our study was prospective, we were not able to collect usable endocrine data or body measurements of all adolescents at all phases of the study. A major problem in the study was drop out due to the start of oral contraceptive pills, about 60% of all participants. This made the number in the various menstrual cycle pattern groups too small for a longitudinal analysis. The data were analyzed in a cross-sectional mode. In each analysis, cases with incomplete data were excluded for that specific analysis. Multiple linear regression analysis (Module 2R) was used to estimate the influence of the number of samples (1, 2, or 3) a participant gave or the phase of the study in which the blood sample was taken on the analysis.

The gynecological age (months) was calculated by subtracting the age at menarche (months) from the calendar age (months). The least squares linear regression equation between gynecological age and body measurements or hormones was calculated by linear regression analysis (module 2R). The effect of logarithmic or polynomial transformation of the dependent variables was evaluated. The equality of the regression lines across the menstrual cycle pattern groups was tested by linear regression by groups (module 1R). Differences in the slopes of the regression lines in the various menstrual cycle groups were evaluated by multiple linear regression, with determinants describing the interaction between menstrual cycle pattern and gynecological age in the regression model (module 2R). The mean hormone levels of girls with regular menstrual cycles vs. those with other menstrual cycle patterns were compared by analysis of covariance to adjust for differences in gynecological age between the various menstrual cycle pattern groups.

Correlation coefficients between the various hormones and body measurements were calculated (Module 6D). The effect of the number of samples per individual on the correlation coefficients was estimated by calculating the partial correlation coefficient adjusted for these determinants (Module 2R).


    Results
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Discussion
 References
 
Development of body measurements and hormones by gynecological age

Table 2Go shows the least squares regression equations of the BMI, waist circumference, hip circumference, WH ratio, pituitary hormones, androgens, E2, insulin, and GI ratio by gynecological age and menstrual cycle pattern. Fig. 1Go illustrates the mean body measurements and hormones by gynecological age in years. In all menstrual cycle pattern subgroups, BMI and waist and hip circumference showed a significant increase by gynecological age (F-ratio, P < 0.05). In the irregular menstrual cycle group, a significant increase by gynecological age was also found for WH ratio. In all menstrual cycle pattern subgroups, LH, T, {Delta}A, and DHEAS showed a significant increase (F-ratio, P < 0.05) during the first 6 yr after menarche. FSH showed no increase, and PRL and E2 showed only a significant increase in the regular menstrual cycle group. No significant association could be documented between gynecological age and insulin or GI ratio.


View this table:
[in this window]
[in a new window]
 
Table 2. Least squares linear regression equations [intercept + ß = increase in 1 yr (SE of ß)] of body measurements and hormone concentrations by gynecological age during the first 6 yr after menarche in adolescents with regular menstrual cycles, irregular menstrual cycles, and oligomenorrhea

 


View larger version (22K):
[in this window]
[in a new window]
 
Figure 1. Mean BMI, waist and hip circumference, WH ratio, LH, T, {Delta}A, and DHEAS concentrations by gynecological age in years in girls with regular menstrual cycles (RMC), irregular menstrual cycles (IMC), and oligomenorrhea (Oligo). Results are based on cross-sectional data analysis. For statistics see Tables 2Go and 3Go. *, All correlations between gynecological age and other parameters were significant, except the correlation with WH ratio in the regular menstrual cycle group and the oligomenorrhea group. {int}, Slope of the regression line of the oligomenorrhea group significantly different from the slope in the regular menstrual cycle group. {oint}, Mean significantly different (P < 0.05) compared with girls with regular menstrual cycles by analysis of covariance to adjust for differences in gynecological age.

 
In a multiple linear regression analysis the number of samples (1, 2, or 3) a participant gave or the phase of the study in which the sample was taken had no independent influence on the relation between gynecological age and hormone levels. Logarithmic or polynomial transformation did not improve the correlation between gynecological age and body measurements or hormones.

Because the regular menstrual cycle group was defined as the reference group including normal subjects, a possible effect of obesity or hirsutism of subjects in this group was evaluated. The prevalences of obesity (BMI >25.0 kg/m2, 4.4%), abnormal body hair (F&G score >0, 10%) or hirsutism (F&G score >7, 1.3%) in the regular menstrual cycle group were low. Exclusion of obese or hirsute girls from the analysis had no effect on the relation between gynecogical age and androgen levels. Exclusion of girls with regular menstrual cycles in one phase of the study and irregular menstrual cycles or oligomenorrhea in another phase of the study also had no significant effect.

Body measurements and hormones by menstrual cycle pattern

Table 3Go shows the mean ± SEM of the body measurements and hormones by menstrual cycle pattern. No significant difference was found in BMI, waist and hip circumference, or WH ratio between the various menstrual cycle pattern groups with analysis of covariance adjusting for differences in gynecological age.


View this table:
[in this window]
[in a new window]
 
Table 3. Body measurements and hormone concentrations during the first 6 yr after menarche by menstrual cycle pattern in adolescents with regular menstrual cycles, irregular menstrual cycles, and oligomenorrhea

 
LH, T, and {Delta}A levels were significantly higher in the oligomenorrhea group compared with the regular menstrual cycle group. DHEAS and PRL levels were higher in the irregular menstrual cycle group compared with the regular menstrual cycle group. PRL concentrations in the irregular menstrual cycle group were also significantly higher than those levels in the oligomenorrhea group. The difference in these levels was rather small: 0.21 U/mL in the regular menstrual cycle group vs. 0.24 U/mL in the irregular menstrual cycle subgroup.

Insulin concentrations did not differ between the menstrual cycle pattern groups. The GI -ratio was significantly lower (P = 0.04) in the regular menstrual cycle group compared with the oligomenorrhea group. The proportion of adolescents with BMI <18 kg/m2 was significantly higher in the oligomenorrhea group (28%) than in the regular menstrual cycle group (7%). After exclusion of these adolescents with low BMI, no significant difference was found in insulin concentrations (10.0 ± 0.4 mU/L vs. 10.1 ± 0.8 mU/L) or GI ratio (9.6 ± 0.4 ng/10-4 U vs. 10.4 ± 0.8 ng/10-4 U) between the regular menstrual cycle group and the oligomenorrhea group. Mean LH, {Delta}A, and T concentrations of oligomenorrheic girls increased by about 5–10% after exclusion of girls with low BMI.

Correlation between androgen or insulin concentrations and BMI and body fat distribution

Table 4Go shows the correlation coefficients between the various body measurements and androgens, insulin, and GI ratio by menstrual cycle pattern. Weak, positive correlations were found between BMI, waist and hip circumference, on one hand, and androgens and insulin concentration, on the other hand. Weak, negative correlations were found between these body measurements and GI ratio. The correlation coefficients in the irregular menstrual cycle group and the oligomenorrhea group did not differ significantly from those in the regular menstrual cycle group.


View this table:
[in this window]
[in a new window]
 
Table 4. Correlation coefficients between body measurements and androgens, insulin, and GI ratio

 
WH ratio showed no significant correlation with androgens. A significant positive correlation between insulin and WH ratio was documented in the regular and irregular menstrual cycle group, 0.28 and 0.59, respectively; a significant negative correlation with GI-ratio was only found in the irregular menstrual cycle group.

Correlation between insulin or LH concentrations and androgen concentrations

Table 5Go shows the correlation coefficients between insulin, GI ratio and LH, on one hand, and androgens, on the other hand. Except for an unexpected negative correlation between T and insulin in the regular menstrual cycle group, no significant correlation could be documented between insulin concentrations or GI ratio and androgen concentrations. LH was significantly correlated with {Delta}A and T in the irregular menstrual cycle group and the oligomenorrhea group. All correlations were low. At most, 22% (0.472) of the variation in androgen levels was explained by variation in LH levels.


View this table:
[in this window]
[in a new window]
 
Table 5. Correlations between insulin, GI ratio, or LH concentrations and androgen concentrations in adolescents by menstrual cycle pattern

 

    Discussion
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Discussion
 References
 
Our data on the combination of body measurements and hormones in relation to gynecological age within a single population are unique. We found a simultaneous increase in LH and androgen concentrations, BMI, and waist and hip circumference in the first 6 yr after menarche in girls with regular menstrual cycles, irregular menstrual cycles, or oligomenorrhea. Compared with the regular menstrual cycle group, LH, {Delta}A, and T concentrations were significantly higher in the oligomenorrhea group. The relations between gynecological age and mean hormone concentrations or body measurements were best described by linear equations. Although Fig. 1Go suggests that the increase in these parameters by gynecological age expressed in years seems bigger in the first 3 yr after menarche, we were not able to identify a gynecological age after which the increase significantly diminished. The hormone levels in the 5th and 6th yr after menarche are comparable with the reference values given by the manufactures of the assays for adults. Although insulin levels are described to be higher at the end of puberty (i.e. Tanner stage 4 and 5) than during prepuberty and adulthood (11, 12, 13, 19, 20, 21), we could not document a significant decrease in basal insulin concentrations or an increase in GI ratio by gynecological age. Because insulin levels were only determined in the second and third phases of the study, a decrease in the first 2 years after menarche may have remained undetected due to a small number of participants (n = 14) with a gynecological age < 2 years.

Limitations of our study are that not all participants had equal numbers of blood samples and the data are mixed cross-sectional and longitudinal. The influence on the results of the number of samples or the phase of the study in which a sample was taken was examined, and no significant influence could be documented. The main reason for drop out was the start of oral contraceptive pills. An influence of this on the analysis cannot be excluded, however, within the menstrual cycle pattern subgroups the baseline characteristics of pill users vs. non-pill users were not different. Another limitation is that we did not document ovulation. Hormone concentrations may differ in ovulatory and anovulatory cycles in adolescents (9, 10, 14, 15). Furthermore, anovulation in the cycle preceding the study cycle may result in higher LH and androgen levels in the follicular phase of the study cycle (31, 32, 33, 34). The prevalence of ovulatory cycles increases from 14–38% in the 1st year after menarche to 65–87% 4–6 yr after menarche (10, 14, 16, 35) Thus, the increase in LH and androgen levels in the various menstrual cycle groups seems to coincide with an increase in prevalence of ovulatory cycles. LH and androgen levels may have been relatively high due to anovulation during first years after menarche and the increase of these hormones may have been stronger if only ovulatory cycles had been studied

No clear explanation can be given for the significant differences in PRL and DHEAS concentrations between girls with regular and irregular menstrual cycles (18). The hormonal pattern in the oligomenorrhea group resembles that seen in adult PCOS and may be a stage in the development of this condition (14, 15, 16, 18, 36). In adults, several observations suggest an important role for hyperinsulinemia in the pathophysiology of hyperandrogenism and the PCOS (22, 23, 24, 25). The insulin-IGF-I hypothesis postulates that progressively rising insulin and IGF-I levels during puberty cause excessive ovarian stimulation and induce a polycystic ovary syndrome in predisposed girls.(37) Our data are not in line with this hypothesis. We found no association between basal insulin concentrations or GI ratio with androgens or menstrual cycle pattern; however, other well-known relationships such as between basal insulin concentrations and BMI or between menstrual cycle pattern and androgen or LH concentrations were confirmed. Apter et al. (38) found insulin insensitivity in six extremely obese girls (BMI >30 kg/m2) with oligomenorrhea and hyperandrogenemia (38). Our group of oligomenorrheic girls was representative for all oligomenorrheic girls in a geographically defined area. Only 10% of these oligomenorrheic girls were obese. Extreme obesity as described in the study of Apter et al. (38) is very rare in our population and in The Netherlands.

Our oligomenorrheic group will be a mixture of girls in whom this menstrual cycle pattern is a stage in their maturation to a regular menstrual cycle pattern and girls who have or will develop PCOS, characterized by oligo- or anovulation with high LH or androgen concentrations. Earlier longitudinal studies on oligomenorrhea or hyperandrogenemia showed that adolescents maintain these characteristics in adulthood (36, 39), suggesting that about 50% of our oligomenorheic girls will develop PCOS as adults. We think a primary, eliciting role for insulin in the development of the PCOS is unlikely. However, an excessive production of androgens by the ovaries in reaction to normal insulin or IGF-I stimulations or an eliciting role in extreme obese girls remains possible. Our data suggest a more prominent role for hyperandrogenism due to enzyme dysregulation or inappropriate LH secretion in the pathophysiology of PCOS. It has also been suggested that adolescent menstrual irregularities are a result of an inoperative LH response to estrogens due to immaturity of the estrogen-induced positive feedback mechanism (40). The fairly high frequency of ovulation in oligomenorrheic girls (65.9%) is in contradiction with this hypothesis (16).

Despite the limitations we mentioned, we think our findings give a true description of these changes in the first years after menarche and of the correlations between these determinants. Because LH and androgens in the years after menarche are lower than in adults, reference values to diagnose hyperandrogenism or inappropriate LH secretion should be adjusted for gynecological age. As a correlation between basal insulin levels or GI ratio and androgen levels or oligomenorrhea is missing, the insulin-IGF-I hypothesis as an explanation for the development of PCOS in puberty is not supported.


    Acknowledgments
 
We are indebted to the girls and the management of the schools that participated in the study. We thank the staff of the endocrine laboratory of Vrije Universiteit Medical Centre (head Dr. C. Popp-Snijders) for performing the hormone determinations.


    Footnotes
 
1 The POMP study (Pubertal Onset of Menstrual Cycle Abnormalities: A Prospective Study) was financially supported by Wyeth Lederle Female Health, The Netherlands, and the Dutch Prevention Fund (project no. 28-2176). Back

Received August 25, 1999.

Revised December 15, 1999.

Accepted December 30, 1999.


    References
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Discussion
 References
 

  1. Sizonenko PC, Burr IM, Kaplan SL, Grumbach MM. 1970 Hormonal changes in puberty: II. Correlation of serum luteinizing hormone and follicle stimulating hormone with stages of puberty and bone age in normal girls. Pediatr Res. 4:36–45.
  2. Kulin HE, Reiter EO. 1973 Gonadotropins during childhood and adolescence: a review. Pediatrics. 51:260–271.[Abstract/Free Full Text]
  3. Sizonenko PC, Paunier L. 1975 Hormonal changes in puberty. III. Correlation of plasma dehydroepiandrosterone, testosterone, FSH and LH with stages of puberty and bone age in normal boys and girls and patients with Addinson’s disease or hypogonadism or with premature or late adrenarche. J Clin Endocrinol Metab. 41:894–904.[Abstract/Free Full Text]
  4. Gupta D, Attanasio A, Raaf S. 1975 Plasma estrogen and androgen concentrations in children during adolescence. J Clin Endocrinol Metab. 40:636–643.[Abstract/Free Full Text]
  5. Lee PA, Xenakis T, Winer J, Matsenbaugh S. 1976 Puberty in girls: correlation of serum levels of gonadotropins, prolactin, androgens, estrogens, and progestins with physical changes. J Clin Endocrinol Metab. 43:775–784.[Abstract/Free Full Text]
  6. Genazzani AR, Pintor C, Facchinetti F, Carboni G, Pelosi U, Corda R. 1978 Adrenal and gonadal steroids in girls during sexual maturation. Clin Endocrinol. 8:15–25.[Medline]
  7. Ilondo MM, Vanderscheuren-Lodeweyckx M, Vlietinck R, et al. 1982 Plasma androgens in children and adolescents. Horm Res. 16:61–77.[Medline]
  8. Apter D, Vihko R. 1977 Serum pregnenolone, progesterone, 17-hydroxyprogesterone, testosterone and 5 {alpha}-dihydrotestosterone during female puberty. J Clin Endocrinol Metab. 45:1039–1048.[Abstract/Free Full Text]
  9. Apter D. 1980 Serum steroids and pituitary hormones in female puberty: a partly longitudinal study. Clin Endocrinol. 12:107–120.[Medline]
  10. Apter D, Vihko R. 1985 Hormonal patterns of the first menstrual cycles. In: Venturoli S, Flamigni C, Givens J, eds. Adolescence in females. Chicago: Year Book Medical Publishers Inc.; 215–238.
  11. Smith CP, Archibald HR, Thomas JM, et al. 1988 Basal and stimulated insulin levels rise with advancing puberty. Clin Endocrinol (Oxf.). 28:7–14.
  12. Smith CP, Dunger DB, Williams AJ, et al. 1989 Relationship between insulin, insulin-like growth factor I, and dehydroepiandrosterone sulfate concentrations during childhood, puberty, and adult life. J Clin Endocrinol Metab. 68:932–937.[Abstract/Free Full Text]
  13. Laron Z, Aurbach Klipper Y, Flasterstein B, Litwin A, Dickerman Z, Heding LG. 1988 Changes in endogenous insulin secretion during childhood as expressed by plasma and urinary C-peptide. Clin Endocrinol (Oxf.). 29:625–632.
  14. Venturoli S, Porcu E, Fabbri R, et al. 1987 Postmenarchal evolution of endocrine pattern and ovarian aspects in adolescents with menstrual irregularities. Fertil Steril. 48:78–85.[Medline]
  15. Venturoli S, Porcu E, Fabbri R, et al. 1985 Hormonal patterns of the first menstrual cycles. In: Venturoli S, Flamigni C, Givens J, eds. Adolescence in females. Chicago: Year Book Medical Publishers Inc.; 239–250.
  16. Siegberg R, Nilsson CG, Stenman UH, Widholm O. 1986 Endocrinologic features of oligomenorrheic adolescent girls. Fertil Steril. 46:852–857.[Medline]
  17. van Hooff MHA, Voorhorst F, Kaptein M, Hirasing R, Koppenaal C, Schoemaker J. 1998 Relationship of the menstrual cycle pattern in 14–17 year old adolescents with gynaecological age, body mass index, historical parameters. Hum Reprod. 13:2252–2260.[Abstract/Free Full Text]
  18. van Hooff MHA, Voorhorst FJ, Kaptein MBH, Hirasing RA, Koppenaal C, Schoemaker J. 1999 Endocrine features of the polycystic ovary syndrome in a random population sample 14–16 year old adolescents. Hum Reprod. 14:2223–2229.[Abstract/Free Full Text]
  19. Amiel SA, Caprio S, Sherwin RS, Plewe G, Haymond MW, Tamborlane WV. 1991 Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism. J Clin Endocrinol Metab. 72:277–282.[Abstract/Free Full Text]
  20. Bloch CA, Clemons P, Sperling MA. 1987 Puberty decreases insulin sensitivity. J Pediatr. 110:481–487.[CrossRef][Medline]
  21. Cook JS, Hoffman RP, Stene MA, Hansen JR. 1993 Effects of maturational stage on insulin sensitivity during puberty. J Clin Endocrinol Metab. 77:725–730.[Abstract]
  22. Franks S. 1995 Polycystic ovary syndrome. N Engl J Med. 333:853–861.[Free Full Text]
  23. Morales AJ, Laughin GA, Bützow T, Maheshwari H, Baumann G, Yen SCC. 1996 Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. J Clin Endocrinol Metab. 81:2854–2864.[Abstract/Free Full Text]
  24. Dunaif A. 1997 Insulin resistance and the polycystic ovary syndrome: mechanisms and implications for pathogenesis. Endocr. Rev. 18:774–800.
  25. Taylor AE. 1998 Polycystic ovary syndrome. Endocrinol Metab Clin North Am 27:877–902.
  26. Siegberg R. 1987 Serum sex hormone concentrations in adolescent secondary amenorrhoea. Ann Chir Gynaecol. 76:176–180.[Medline]
  27. Westrate JA, Deurenberg J, Van Tinteren H. 1989 Indices of body fat distribution and adiposity in Dutch children from birth to 18 years of age. Int J Obesity. 13:465–477.[Medline]
  28. Ferriman D, Gallwey JD. 1961 Clinical assesment of body hair growth in women. J Clin Endocrinol Metab. 21:1440–1447.
  29. Anttila L, Koskinen P, Kaihola HL, Erkkola R, Irjala K, Ruutiainen K. 1992 Serum androgen and gonadotropin levels decline after progestogen-induced withdrawal bleeding in oligomenorrheic women with or without polycystic ovaries. Fertil Steril. 58:697–702.[Medline]
  30. Minakami H, Abe N, Izumi A, Tamada T. 1988 Serum luteinizing hormone profile during the menstrual cycle in polycystic ovarian syndrome. Fertil Steril. 50:990–992.[Medline]
  31. Taylor AE, McCourt B, Martin KA, et al. 1997 Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab. 82:2248–2256.[Abstract/Free Full Text]
  32. van Hooff MHA, van der Meer M, Lambalk CB, Schoemaker J. 1999 Variation of LH and androgens in oligomenorrhea and its implications for the study of the polycystic ovary syndrome. Hum Reprod. 14:1684–1689.[Abstract/Free Full Text]
  33. Wu CH, Mikhail G. 1979 Plasma hormone profile in anovulation. Fertil Steril. 31:258–266.[Medline]
  34. Martins JM, Carreiras F, Afonso A, Falcao J, Charneco da Costa J. Transient hyperandrogenemia and its relation to ovulation. Fertil Steril 1998:70:664–670.
  35. Metcalf MG, Skidmore DS, Lowry GF, Mackenzie JA. 1983 Incidence of ovulation in the years after the menarche. J Endocrinol. 97:213–219.[Abstract/Free Full Text]
  36. Apter D, Vihko R. 1990 Endocrine determinants of fertility: serum androgen concentrations during follow-up of adolescents into the third decade of life. J Clin Endocrinol Metab. 71:970–974.[Abstract/Free Full Text]
  37. Nobels F, Dewailly D. 1992 Puberty and polycystic ovarian syndrome: the insulin/insulin-like growth factor I hypothesis. Fertil Steril. 58:655–666.[Medline]
  38. Apter D, Bützow T, Laughlin A, Yen SSC. 1995 Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism. J Clin Endocrinol Metab. 80:2966–2973.[Abstract/Free Full Text]
  39. Southam AL, Richart RM. 1966 1966 The prognosis for adolescents with menstrual abnormalities. Am J Obstet Gynecol. 94:637–645.[Medline]
  40. Reiter EO, Kulin HE, Hamwood SM. 1974 The absence of positive feedback between estrogen and luteinizing hormone in sexually immature girls. Pediatr Res. 8:740–745.



This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
R. J. Chang
Obesity and the Emergence of Sleep-Wake Gonadotropin Secretion in Girls during Early Pubertal Development
J. Clin. Endocrinol. Metab., April 1, 2009; 94(4): 1094 - 1096.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Zhang, S. Pollack, A. Ghods, C. Dicken, B. Isaac, G. Adel, G. Zeitlian, and N. Santoro
Onset of Ovulation after Menarche in Girls: A Longitudinal Study
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1186 - 1194.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
H. J. Baer, G. A. Colditz, W. C. Willett, and J. F. Dorgan
Adiposity and Sex Hormones in Girls
Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1880 - 1888.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. R. McCartney, S. K. Blank, K. A. Prendergast, S. Chhabra, C. A. Eagleson, K. D. Helm, R. Yoo, R. J. Chang, C. M. Foster, S. Caprio, et al.
Obesity and Sex Steroid Changes across Puberty: Evidence for Marked Hyperandrogenemia in Pre- and Early Pubertal Obese Girls
J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 430 - 436.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. S. Tworoger, A. H. Eliassen, S. A. Missmer, H. Baer, J. Rich-Edwards, K. B. Michels, R. L. Barbieri, M. Dowsett, and S. E. Hankinson
Birthweight and Body Size throughout Life in Relation to Sex Hormones and Prolactin Concentrations in Premenopausal Women
Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2494 - 2501.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. R. McCartney, K. A. Prendergast, S. Chhabra, C. A. Eagleson, R. Yoo, R. J. Chang, C. M. Foster, and J. C. Marshall
The Association of Obesity and Hyperandrogenemia during the Pubertal Transition in Girls: Obesity as a Potential Factor in the Genesis of Postpubertal Hyperandrogenism
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1714 - 1722.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Chhabra, C. R. McCartney, R. Y. Yoo, C. A. Eagleson, R. J. Chang, and J. C. Marshall
Progesterone Inhibition of the Hypothalamic Gonadotropin-Releasing Hormone Pulse Generator: Evidence for Varied Effects in Hyperandrogenemic Adolescent Girls
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2810 - 2815.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. A.M. de Boer, C. B. Lambalk, H. H. Hendriks, C. van Aken, E. A. van der Veen, and J. Schoemaker
Growth hormone secretion is impaired but not related to insulin sensitivity in non-obese patients with polycystic ovary syndrome
Hum. Reprod., March 1, 2004; 19(3): 504 - 509.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M.H.A. van Hooff, F.J. Voorhorst, M.B.H. Kaptein, R.A. Hirasing, C. Koppenaal, and J. Schoemaker
Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years
Hum. Reprod., February 1, 2004; 19(2): 383 - 392.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
F. Clavel-Chapelon
Evolution of age at menarche and at onset of regular cycling in a large cohort of French women
Hum. Reprod., January 1, 2002; 17(1): 228 - 232.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Hooff, M. H. A.
Right arrow Articles by Schoemaker, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Hooff, M. H. A.
Right arrow Articles by Schoemaker, J.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals